(NASDAQ: FRMM) Forum Markets's forecast annual revenue growth rate of 183.55% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 183.48%.
Forum Markets's revenue in 2026 is $6,547,000.On average, 3 Wall Street analysts forecast FRMM's revenue for 2026 to be $377,092,593, with the lowest FRMM revenue forecast at $362,304,648, and the highest FRMM revenue forecast at $388,183,551.
In 2027, FRMM is forecast to generate $1,004,889,601 in revenue, with the lowest revenue forecast at $965,482,166 and the highest revenue forecast at $1,034,445,178.